Osunprotafib
Osunprotafib (ABBV-CLS-484) is an oral PTP1B/PTPN2 inhibitor in clinical development for oncology. It modulates the tumor microenvironment to enhance anti-tumor immunity by potentiating JAK-STAT signaling in NK and CD8+ T cells, thereby reducing T cell exhaustion, as evidenced in preclinical in vivo studies.
Product Specifications
CAS Number
2489404-97-7
Product Name Alternative
Osunprotafib, AC 484, AC 484, ABBV-CLS 484, ABBV-CLS484, ABBV-CLS-484, AC484, AC-484, protein tyrosine phosphatase (PTP)
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Metabolism Research, Signal Transduction, Stem Cell & Developmental Biology
Purity
97.11% (May vary between batches)
Form
Powder
Solubility
DMSO: 56.2 mg/mL (145.9 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble)
Smiles
CC (C) CCN[C@@H]1CCc2cc (O) c (N3CC (=O) NS3 (=O) =O) c (F) c2C1
Molecular Formula
C17H24FN3O4S
Molecular Weight
385.45
Storage Conditions
Powder: -20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-TMEM59 Antibody Picoband® Fluoro594 Conjugated
West Nile Virus, Core, CT (WNV Core, Capsid Protein C) (HRP)
AVIL sgRNA CRISPR Lentivector (Human) (Target 2)